GSK execs take financial and medical reins at Adaptimmune
This article was originally published in Scrip
Executive Summary
Adaptimmune, a clinical-stage biotechnology company focused on the use of T-cell therapy to treat cancer, has named Dr Rafael Amado chief medical officer and Adrian Rawcliffe chief financial officer – effective from 16 March 2015.